Skip to main content

Table 1 Baseline characteristics of study sample. Mean (SD)

From: Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis

  0.03 mg
(N = 7)
0.1 mg
(N = 6)
0.3 mg
(N = 6)
1 mg
(N = 6)
All
(N = 25)
Placebo
(N = 8)
All Participants
(N = 33)
Age in years 60.1 (11.2) 58.5 (5.3) 62.2 (15.8) 58.5 (5.6) 59.8 (9.9) 59.8 (6.5) 59.8 (9.1)
BMI. kg/m 2 35.7 (8.7) 35.6 (10.9) 33.0 (7.2) 35.8 (8.2) 35.0 (8.3) 31.6 (5.8) 34.2 (7.9)
Gender
(n (%) female)
3 (43%) 6 (100%) 5 (83%) 4 (67%) 18 (72%) 6 (75%) 24 (73%)